Company / Operating Income
Glaukos Corp. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$199.6M
FY2025
5-year range
-$199.6M / -$32.9M
FY2021-FY2025
Trend
-63.1%
vs FY2024
Sector context
#139 of 156
Health Care
What the data says
Glaukos Corp.'s operating income of -$200M is lower than 89% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$200M in FY2025 to $4M in FY2018.
Based on SEC 10-K filings.
-$200M in FY2025.
Declined from -$33M to -$200M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 156This company -$199.6M Sector average $733.1M
▼
-127.2% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 63.1% year-over-year.
- Ranks #139 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$199.6M | -63.1% |
| FY2024 | -$122.4M | -272.2% |
| FY2023 | -$32.9M | +73.4% |
| FY2022 | -$123.6M | -145.7% |
| FY2021 | -$50.3M | -286.8% |
| FY2020 | -$13.0M | -470.0% |
| FY2019 | -$2.3M | -153.8% |
| FY2018 | $4.2M | +141.2% |
| FY2017 | -$10.3M | -342.8% |
| FY2016 | $4.2M | +129.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026